Volume 48, Issue 6 , Pages 964-971, December 2006
Differences in Use of Peritoneal Dialysis and Survival Among East Asian, Indo Asian, and White ESRD Patients in Canada
Background: Racial differences in health outcomes in general are well documented; however, few studies examined the impact of East Asian and Indo Asian race on choice of dialytic modality and survival among patients with end-stage renal disease (ESRD). Methods: We compared the use of peritoneal dialysis (PD) and survival among East Asian, Indo Asian, and white patients with ESRD initiating dialysis therapy in Canada between January 1, 1990, and December 31, 2000. Results: Of 10,338 patients, 5.7% were East Asian, 3.2% were Indo Asian, and 91% were white. After controlling for sociodemographics and comorbidities, East Asian and Indo Asian patients were significantly more likely to initiate dialysis therapy on PD compared with white patients (odds ratio, 1.63; 95% confidence interval [CI], 1.36 to 1.96; odds ratio, 1.52; 95% CI, 1.21 to 1.93, respectively), with no difference in likelihood of technique failure. East Asian and Indo Asian patients had a lower risk for death after the initiation of dialysis therapy (irrespective of modality) compared with white patients, with adjusted hazard ratios of 0.66 (95% CI, 0.58 to 0.76) for East Asian patients and 0.63 (95% CI, 0.53 to 0.75) for Indo Asian patients. The survival benefit for East Asian and Indo Asian patients was similar in the subgroup that initiated dialysis therapy with PD. Conclusion: We found that Asian patients with ESRD were more likely to initiate dialysis therapy using PD, with improved survival after the initiation of dialysis therapy, compared with white patients. Elucidation of factors in East Asian and Indo Asian ESRD populations that result in improved outcomes may have implications for ESRD treatment for other racial groups.
Index words: Renal dialysis, chronic kidney failure, mortality, Asian
To access this article, please choose from the options below
Support: B.R.H., B.J.M., N.A.K., and M.T. are supported by New Investigator Awards from the Canadian Institutes of Health Research. B.R.H. and M.T. also are supported by Population Health Investigator Awards from the Alberta Heritage Foundation for Medical Research. J.S.G. is supported by the Michael Smith Foundation for Medical Research. The Canadian Organ Replacement Register is funded 15% by the federal department of health and 80% by the provincial and territorial departments of health based on population. Together, the Kidney Foundation of Canada and the health care industry provide approximately 5% of the funding. Potential conflicts of interest: None.Originally published online as doi:10.1053/j.ajkd.2006.08.021 on October 18, 2006.
PII: S0272-6386(06)01370-9
doi:10.1053/j.ajkd.2006.08.021
© 2006 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
Refers to erratum:
- Erratum
Volume 48, Issue 6 , Pages 964-971, December 2006
